JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $7

JMP Securities maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $9 to $7.

Benzinga · 11/13/2019 12:40

JMP Securities maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $9 to $7.